Omega Fund Management, LLC
Boston, MA · CIK 1637359 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2012 · limited liability company
- Assets managed$1.7bn
- Staff21 · 8 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds5 · $914.4m gross assets
- Websiteomegafunds.com
- Form ADV · 2026-03-26SEC adviser record
- Kindprivate equity, venture
- Others nearbyBoston, MA, Geneva
As an employer
- Offices in2 countries
- Private fundsventure capital 3, private equity 2
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Boston, MA (main office)United States | about 5 |
| GenevaSwitzerland | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$185.7m
reported value
+13.8% vs Q1 2026
10positions
100.0%in top 10
1 new
0 added
1 reduced
1 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BICARA THERAPEUTICS INC BCAX | $54.1m29.14% | Reduced -570.0k |
| NUVATION BIO INC NUVB | $45.9m24.72% | Unchanged |
| KESTRA MED TECHNOLOGIES LTD KMTS | $26.0m14.00% | Unchanged |
| BRIDGEBIO ONCOLOGY THERAPEUT BBOT | $25.1m13.50% | Unchanged |
| BETA BIONICS INC BBNX | $20.6m11.11% | Unchanged |
| ALUMIS INC ALMS | $6.8m3.66% | Unchanged |
| SANA BIOTECHNOLOGY INC SANA | $2.9m1.59% | Unchanged |
| IMAGENEBIO INC IMA | $2.7m1.45% | Unchanged |
| ENGENE HOLDINGS INC COM | $1.5m0.82% | Unchanged |
| ODYSSEY THERAPEUTICS INC ODTX | $54.1k0.03% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| REPLIMUNE GROUP INC REPL | $1.9m248.7k shares |